Edition:
India

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

92.20SEK
16 Jan 2018
Change (% chg)

-1.10kr (-1.18%)
Prev Close
93.30kr
Open
92.90kr
Day's High
92.90kr
Day's Low
91.10kr
Volume
48,031
Avg. Vol
18,813
52-wk High
108.00kr
52-wk Low
78.25kr

Chart for

About

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO... (more)

Overall

Beta: 0.44
Market Cap(Mil.): kr2,461.91
Shares Outstanding(Mil.): 26.19
Dividend: --
Yield (%): --

Financials

BRIEF-Xvivo Q3 EBITDA ex-items at SEK 4.4 million

* Q3 NET SALES SEK ‍32.3​ MILLION VERSUS SEK 31.7 MILLION YEAR AGO

27 Oct 2017

BRIEF-Xvivo Perfusion's CFO Christoffer Rosenblad appointed deputy CEO

* ‍CFO CHRISTOFFER ROSENBLAD HAS BEEN APPOINTED DEPUTY CEO WITH EFFECT FROM JULY 17, 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

17 Jul 2017

Earnings vs. Estimates